HemaSphere
(Aug 2023)
P1036: REAL-WORLD EFFICACY AND SAFETY OF MIDOSTAURIN-TREATMENT IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS
- Johannes Lübke,
- Nicole Naumann,
- Georgia Metzgeroth,
- Alice Fabarius,
- Timo Brand,
- Hans-Peter Horny,
- Karl Sotlar,
- Wolf-Karsten Hofmann,
- Juliana Schwaab,
- Andreas Reiter
Affiliations
- Johannes Lübke
- 1 University Hospital Mannheim, Department of Hematology and Oncology, Mannheim, Germany
- Nicole Naumann
- 1 University Hospital Mannheim, Department of Hematology and Oncology, Mannheim, Germany
- Georgia Metzgeroth
- 1 University Hospital Mannheim, Department of Hematology and Oncology, Mannheim, Germany
- Alice Fabarius
- 1 University Hospital Mannheim, Department of Hematology and Oncology, Mannheim, Germany
- Timo Brand
- 1 University Hospital Mannheim, Department of Hematology and Oncology, Mannheim, Germany
- Hans-Peter Horny
- 2 Ludwig-Maximilians-University, Department of Pathology, München, Germany
- Karl Sotlar
- 3 Paracelsus Medical University of Salzburg, Department of Pathology, Salzburg, Austria
- Wolf-Karsten Hofmann
- 1 University Hospital Mannheim, Department of Hematology and Oncology, Mannheim, Germany
- Juliana Schwaab
- 1 University Hospital Mannheim, Department of Hematology and Oncology, Mannheim, Germany
- Andreas Reiter
- 1 University Hospital Mannheim, Department of Hematology and Oncology, Mannheim, Germany
- DOI
-
https://doi.org/10.1097/01.HS9.0000971040.47281.9b
- Journal volume & issue
-
Vol. 7
p.
e472819b
WeChat QR code